ENFORTUMAB VEDOTIN
UNII DLE8519RWM

Substance Identification & Data

This profile provides standardized clinical and technical data for Enfortumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DLE8519RWM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1346452-25-2 and the RxNorm Concept ID (RxCUI) 2268306. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DLE8519RWM

CAS Registry Number

1346452-25-2

RxNorm Concept ID

2268306

Detailed Substance Profile

Preferred Name

ENFORTUMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DLE8519RWM

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C114500

National Cancer Institute reference terminology for clinical and research data.

INN ID

9821

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-32

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enfortumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.